Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2015

01-06-2015 | Original Research

Diagnosis and Treatment of Incident Hypertension Among Patients with Diabetes: a U.S. Multi-Disciplinary Group Practice Observational Study

Authors: Margaret L. Wallace, PharmD MS, Elizabeth M. Magnan, MD, Carolyn T. Thorpe, PhD MPH, Jessica R. Schumacher, PhD, Maureen A. Smith, MD PhD MPH, Heather M. Johnson, MD MS

Published in: Journal of General Internal Medicine | Issue 6/2015

Login to get access

ABSTRACT

BACKGROUND

Early hypertension control reduces the risk of cardiovascular complications among patients with diabetes mellitus. There is a need to improve hypertension management among patients with diabetes mellitus.

OBJECTiVE

We aimed to evaluate rates and associations of hypertension diagnosis and treatment among patients with diabetes mellitus and incident hypertension.

DESIGN

This was a 4-year retrospective analysis of electronic health records.

PARTICIPANTS

Adults ≥18 years old (n = 771) with diabetes mellitus, who met criteria for incident hypertension and received primary care at a large, Midwestern academic group practice from 2008 to 2011 were included

MAIN MEASURES

Cut-points of 130/80 and 140/90 mmHg were used to identify incident cases of hypertension. Kaplan-Meier analysis estimated the probability of receiving: 1) an initial hypertension diagnosis and 2) antihypertensive medication at specific time points. Cox proportional-hazard frailty models (HR; 95 % CI) were fit to identify associations of time to hypertension diagnosis and treatment.

KEY RESULTS

Among patients with diabetes mellitus who met clinical criteria for hypertension, 41 % received a diagnosis and 37 % received medication using the 130/80 mmHg cut-point. At the 140/90 mmHg cut-point, 52 % received a diagnosis and 49 % received medication. Atrial fibrillation (HR 2.18; 1.21–4.67) was associated with faster diagnosis rates; peripheral vascular disease (HR 0.18; 0.04–0.74) and fewer primary care visits (HR 0.93; 0.88–0.98) were associated with slower diagnosis rates. Atrial fibrillation (HR 3.07; 1.39–6.74) and ischemic heart disease/congestive heart failure (HR 2.16; 1.24–3.76) were associated with faster treatment rates; peripheral vascular disease (HR 0.16; 0.04–0.64) and fewer visits (HR 0.93; 0.88–0.98) predicted slower medication initiation. Diagnosis and treatment of incident hypertension were similar using cut-points of 130/80 and 140/90 mmHg.

CONCLUSIONS

Among patients with diabetes mellitus, even using a cut-point of 140/90 mmHg, approximately 50 % remained undiagnosed and untreated for hypertension. Future interventions should target patients with multiple comorbidities to improve hypertension and diabetes clinical care.
Literature
1.
go back to reference American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(1):S14–80.CrossRef American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(1):S14–80.CrossRef
2.
go back to reference Parati G, Bilo G, Ochoa JE. Benefits of tight blood pressure control in diabetic patients with hypertension: importance of early and sustained implementation of effective treatment strategies. Diabetes Care. 2011;34(2):S297–303.CrossRefPubMedCentralPubMed Parati G, Bilo G, Ochoa JE. Benefits of tight blood pressure control in diabetic patients with hypertension: importance of early and sustained implementation of effective treatment strategies. Diabetes Care. 2011;34(2):S297–303.CrossRefPubMedCentralPubMed
3.
go back to reference de Burgos-Lunar C, Del Cura-González I, Salinero-Fort MA, Gómez-Campelo P, Pérez de Isla L, Jiménez-García R. Delayed diagnosis of hypertension in diabetic patients monitored in primary care. Rev Esp Cardiol. 2013;66:700–6. de Burgos-Lunar C, Del Cura-González I, Salinero-Fort MA, Gómez-Campelo P, Pérez de Isla L, Jiménez-García R. Delayed diagnosis of hypertension in diabetic patients monitored in primary care. Rev Esp Cardiol. 2013;66:700–6.
4.
go back to reference Hatahet MA, Bowhan J, Clough EA. Wisconsin Collaborative for Healthcare Quality (WCHQ): lessons learned. WMJ. 2004;103:45–8.PubMed Hatahet MA, Bowhan J, Clough EA. Wisconsin Collaborative for Healthcare Quality (WCHQ): lessons learned. WMJ. 2004;103:45–8.PubMed
6.
go back to reference Thorpe CT, Flood GE, Kraft SA, Everett CM, Smith MA. Effect of patient selection method on provider group performance estimates. Med Care. 2011;49:780–5.CrossRefPubMedCentralPubMed Thorpe CT, Flood GE, Kraft SA, Everett CM, Smith MA. Effect of patient selection method on provider group performance estimates. Med Care. 2011;49:780–5.CrossRefPubMedCentralPubMed
7.
go back to reference Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.CrossRefPubMed
8.
go back to reference Myers MG, Tobe SW, McKay DW, et al. New algorithm for the diagnosis of hypertension. Am J Hypertens. 2005;18:1369–74.CrossRefPubMed Myers MG, Tobe SW, McKay DW, et al. New algorithm for the diagnosis of hypertension. Am J Hypertens. 2005;18:1369–74.CrossRefPubMed
9.
go back to reference Schmittdiel J, Selby JV, Swain B, et al. Missed opportunities in cardiovascular disease prevention?: low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics. Hypertension. 2011;57:717–22.CrossRefPubMedCentralPubMed Schmittdiel J, Selby JV, Swain B, et al. Missed opportunities in cardiovascular disease prevention?: low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics. Hypertension. 2011;57:717–22.CrossRefPubMedCentralPubMed
10.
11.
go back to reference Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM. Identifying persons with diabetes using Medicare claims data. Am J Med Qual. 1999;14:270–7.CrossRefPubMed Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM. Identifying persons with diabetes using Medicare claims data. Am J Med Qual. 1999;14:270–7.CrossRefPubMed
12.
go back to reference Sheehy AM, Flood GE, Tuan WJ, Liou JI, Coursin DB, Smith MA. Analysis of guidelines for screening diabetes mellitus in an ambulatory population. Mayo Clin Proc. 2010;85:27–35.CrossRefPubMedCentralPubMed Sheehy AM, Flood GE, Tuan WJ, Liou JI, Coursin DB, Smith MA. Analysis of guidelines for screening diabetes mellitus in an ambulatory population. Mayo Clin Proc. 2010;85:27–35.CrossRefPubMedCentralPubMed
13.
go back to reference Tu K, Chen Z, Lipscombe LL, Canadian Hypertension Education Program Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ. 2008;178:1429–35.CrossRefPubMedCentralPubMed Tu K, Chen Z, Lipscombe LL, Canadian Hypertension Education Program Outcomes Research Taskforce. Prevalence and incidence of hypertension from 1995 to 2005: a population-based study. CMAJ. 2008;178:1429–35.CrossRefPubMedCentralPubMed
14.
go back to reference Manson JM, McFarland B, Weiss S. Use of an automated database to evaluate markers for early detection of pregnancy. Am J Epidemiol. 2001;154:180–7.CrossRefPubMed Manson JM, McFarland B, Weiss S. Use of an automated database to evaluate markers for early detection of pregnancy. Am J Epidemiol. 2001;154:180–7.CrossRefPubMed
15.
go back to reference Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.CrossRefPubMed Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.CrossRefPubMed
16.
go back to reference James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.CrossRefPubMed James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.CrossRefPubMed
17.
go back to reference Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298:874–9.CrossRefPubMed Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298:874–9.CrossRefPubMed
18.
go back to reference Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med. 2007;5:196–201.CrossRefPubMedCentralPubMed Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med. 2007;5:196–201.CrossRefPubMedCentralPubMed
19.
go back to reference O’Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Blitz G. Clinical Inertia and Outpatient Medical Errors. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville: Agency of Healthcare Research and Quality (US); 2005:293–308. O’Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Blitz G. Clinical Inertia and Outpatient Medical Errors. In: Henriksen K, Battles JB, Marks ES, Lewin DI, eds. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville: Agency of Healthcare Research and Quality (US); 2005:293–308.
20.
go back to reference Huebschmann AG, Mizrahi T, Soenksen A, Beaty BL, Denberg TD. Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial. J Clin Hypertens (Greenwich). 2012;14:322–9.CrossRefPubMedCentral Huebschmann AG, Mizrahi T, Soenksen A, Beaty BL, Denberg TD. Reducing clinical inertia in hypertension treatment: a pragmatic randomized controlled trial. J Clin Hypertens (Greenwich). 2012;14:322–9.CrossRefPubMedCentral
21.
go back to reference Gil-Guillén V, Orozco-Beltrán D, Peréz RP, et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press. 2010;19:3–10.CrossRefPubMed Gil-Guillén V, Orozco-Beltrán D, Peréz RP, et al. Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press. 2010;19:3–10.CrossRefPubMed
23.
go back to reference Goldstein LB. Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke. 1998;29:1602–4.CrossRefPubMed Goldstein LB. Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke. 1998;29:1602–4.CrossRefPubMed
24.
go back to reference Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.CrossRefPubMed Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.CrossRefPubMed
25.
go back to reference Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Identifying hypertension-related comorbidities from administrative data: what’s the optimal approach? Am J Med Qual. 2004;19:201–6.CrossRefPubMed Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Identifying hypertension-related comorbidities from administrative data: what’s the optimal approach? Am J Med Qual. 2004;19:201–6.CrossRefPubMed
26.
go back to reference Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–95.CrossRefPubMed Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–95.CrossRefPubMed
27.
go back to reference Newton KM, Wagner EH, Ramsey SD, et al. The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol. 1999;52:199–207.CrossRefPubMed Newton KM, Wagner EH, Ramsey SD, et al. The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol. 1999;52:199–207.CrossRefPubMed
28.
go back to reference Taylor DH Jr, Ostbye T, Langa KM, Weir D, Plassman BL. The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. J Alzheimers Dis. 2009;17:807–15.PubMedCentralPubMed Taylor DH Jr, Ostbye T, Langa KM, Weir D, Plassman BL. The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. J Alzheimers Dis. 2009;17:807–15.PubMedCentralPubMed
29.
go back to reference Druss BG, Marcus SC, Olfson M, Tanielian T, Pincus HA. Trends in care by nonphysician clinicians in the United States. N Engl J Med. 2003;348:130–7.CrossRefPubMed Druss BG, Marcus SC, Olfson M, Tanielian T, Pincus HA. Trends in care by nonphysician clinicians in the United States. N Engl J Med. 2003;348:130–7.CrossRefPubMed
30.
go back to reference Pham HH, Schrag D, Hargraves JL, Bach PB. Delivery of preventive services to older adults by primary care physicians. JAMA. 2005;294:473–81.CrossRefPubMed Pham HH, Schrag D, Hargraves JL, Bach PB. Delivery of preventive services to older adults by primary care physicians. JAMA. 2005;294:473–81.CrossRefPubMed
31.
go back to reference Gutierrez RG, StataCorp. Parametric frailty and shared frailty survival models. The Stata Journal. 2002;2:22–44. Gutierrez RG, StataCorp. Parametric frailty and shared frailty survival models. The Stata Journal. 2002;2:22–44.
32.
go back to reference McGilchrist CA, Aisbett CW. Regression with frailty in survival analysis. Biometrics. 1991;47:461–6.CrossRefPubMed McGilchrist CA, Aisbett CW. Regression with frailty in survival analysis. Biometrics. 1991;47:461–6.CrossRefPubMed
33.
go back to reference Brooks EL, Preis SR, Hwang SJ, et al. Health insurance and cardiovascular disease risk factors. Am Med J. 2010;123:741–7.CrossRef Brooks EL, Preis SR, Hwang SJ, et al. Health insurance and cardiovascular disease risk factors. Am Med J. 2010;123:741–7.CrossRef
34.
go back to reference Johnson HM, Thorpe CT, Bartels CM, et al. Antihypertensive medication initiation among young adults with regular primary care use. J Gen Intern Med. 2014;29:723–31.CrossRefPubMedCentralPubMed Johnson HM, Thorpe CT, Bartels CM, et al. Antihypertensive medication initiation among young adults with regular primary care use. J Gen Intern Med. 2014;29:723–31.CrossRefPubMedCentralPubMed
35.
go back to reference Nguyen QC, Waddell EN, Thomas JC, Huston SL, Kerker BD, Gwynn RC. Awareness, treatment, and control of hypertension and hypercholesterolemia among insured residents of New York City, 2004. Prev Chronic Dis. 2011;8:A109.PubMedCentralPubMed Nguyen QC, Waddell EN, Thomas JC, Huston SL, Kerker BD, Gwynn RC. Awareness, treatment, and control of hypertension and hypercholesterolemia among insured residents of New York City, 2004. Prev Chronic Dis. 2011;8:A109.PubMedCentralPubMed
36.
go back to reference Pentakota SR, Rajan M, Fincke BG, et al. Does diabetes care differ by type of chronic comorbidity?: An evaluation of the Piette and Kerr framework. Diabetes Care. 2012;35:1285–92.CrossRefPubMedCentralPubMed Pentakota SR, Rajan M, Fincke BG, et al. Does diabetes care differ by type of chronic comorbidity?: An evaluation of the Piette and Kerr framework. Diabetes Care. 2012;35:1285–92.CrossRefPubMedCentralPubMed
37.
go back to reference Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29:725–31.CrossRefPubMed Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29:725–31.CrossRefPubMed
38.
go back to reference Turner BJ, Hollenbeak CS, Weiner M, Ten Have T, Tang SS. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med. 2008;148:578–86.CrossRefPubMed Turner BJ, Hollenbeak CS, Weiner M, Ten Have T, Tang SS. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med. 2008;148:578–86.CrossRefPubMed
39.
40.
go back to reference Leal S, Glover JJ, Herrier RN, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care. 2004;27:2983–4.CrossRefPubMed Leal S, Glover JJ, Herrier RN, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care. 2004;27:2983–4.CrossRefPubMed
41.
go back to reference Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41:1569–82.CrossRefPubMed Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41:1569–82.CrossRefPubMed
42.
go back to reference Vogeli C, Shields AE, Lee TA, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med. 2007;22(3):391–5.CrossRefPubMedCentralPubMed Vogeli C, Shields AE, Lee TA, et al. Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med. 2007;22(3):391–5.CrossRefPubMedCentralPubMed
43.
go back to reference Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 2001;24:1614–9.CrossRefPubMed Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 2001;24:1614–9.CrossRefPubMed
44.
go back to reference Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care. 2009;32:1851–6.CrossRefPubMedCentralPubMed Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care. 2009;32:1851–6.CrossRefPubMedCentralPubMed
Metadata
Title
Diagnosis and Treatment of Incident Hypertension Among Patients with Diabetes: a U.S. Multi-Disciplinary Group Practice Observational Study
Authors
Margaret L. Wallace, PharmD MS
Elizabeth M. Magnan, MD
Carolyn T. Thorpe, PhD MPH
Jessica R. Schumacher, PhD
Maureen A. Smith, MD PhD MPH
Heather M. Johnson, MD MS
Publication date
01-06-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 6/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3202-0

Other articles of this Issue 6/2015

Journal of General Internal Medicine 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine